We examine the most commercially important biotherapeutics now, and in the future.

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

What is the current state of pharma contract development and manufacturing?

No dinosaurs were harmed in the making of this vaccine…

Nominations for the 2018 Innovation Awards are open!

Biosimilars had their big break in the US in 2015, but three years later biosimilars are still struggling to make a mark.

Sitting Down With Cyrus Krakaria, President of Biotechnology for Lupin Limited, Biotech Division, India.

Initially, The American College of Rheumatology was cautious about biosimilars, but times have changed.

Why does the full potential of biosimilars remain untapped? Four experts weigh in.

Pharmacy students take medicine safety lessons to school classrooms.